What is OrthoPediatrics?
OrthoPediatrics Corp. operates as a specialized medical device manufacturer dedicated to the unique anatomical requirements of pediatric patients. By designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces, the company addresses critical gaps in the orthopedic market. Its product portfolio is segmented into pediatric trauma and deformity correction, scoliosis procedures for spinal deformity, and sports medicine solutions. This focus on pediatric-specific technology positions the company as a leader in a niche yet essential segment of the healthcare industry, ensuring that children receive treatment options tailored to their developmental needs rather than repurposed adult devices.
How much funding has OrthoPediatrics raised?
OrthoPediatrics has raised a total of $100M across 1 funding round:
Other Financing Round
$100M
Other Financing Round (2024): $100M with participation from Braidwell
Key Investors in OrthoPediatrics
Braidwell
Braidwell is a specialized investment firm that provides flexible capital and strategic partnership to organizations transforming human health across public and private markets.
What's next for OrthoPediatrics?
With the recent infusion of capital, OrthoPediatrics is well-positioned to accelerate its research and development pipeline and enhance its international distribution capabilities. The company is expected to leverage this financial backing to deepen its penetration in existing markets while exploring new therapeutic areas within pediatric orthopedics. As the firm transitions into this next phase of growth, the focus will likely remain on maintaining its competitive advantage through clinical innovation and strategic partnerships. By optimizing its capital structure, OrthoPediatrics aims to sustain its long-term growth trajectory, ensuring that its specialized medical solutions remain accessible to healthcare providers and patients globally.
See full OrthoPediatrics company page
